NCT01266980View on ClinicalTrials.gov

A Study to Assess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment.

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 18, 2010

Primary Completion Date

March 22, 2011

Study Completion Date

March 22, 2011

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Inhaled FF/ GW642444M (200/25mcg)

All subjects will be assigned to take FF/ GW642444M (200/25mcg) combination once daily for 7 days.

Trial Locations (1)

170 00

GSK Investigational Site, Prague

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01266980 - A Study to Assess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment. | Biotech Hunter | Biotech Hunter